Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund Elanco Animal Health stake
total: 96
Mairs & Power Growth Fund ELAN trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2019 Q3
- Held for:
- 9 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Mairs & Power Growth Fund doesn't hold any Elanco Animal Health (ELAN) shares. To date, the estimated cost basis is nearly $28.17 for "buy" trades and estimated average "sell" price is $32.31. Mairs & Power Growth Fund first purchased ELAN in 2019 Q3, initially acquiring 225,527 shares. Since the initial investment in Elanco Animal Health (ELAN), Mairs & Power Growth Fund has made 3 more transactions.
When did Mairs & Power Growth Fund sell Elanco Animal Health (ELAN)?
Mairs & Power Growth Fund sold off the entire Elanco Animal Health (ELAN) position in 2021 Q4.
When did Mairs & Power Growth Fund buy Elanco Animal Health (ELAN)?
Mairs & Power Growth Fund first invested in Elanco Animal Health (ELAN) in 2019 Q3 at the reported quarter-end price of $26.59 per share.
What's the cost basis of Mairs & Power Growth Fund's ELAN stake?
The estimated cost basis for Elanco Animal Health (ELAN) stake is around $28.17 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $28.17
- Weighted AVG sell price:
- $32.30
Mairs & Power Growth Fund's historical trades in Elanco Animal Health
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$31.89
|
|
-100% (-430,527)
|
-0.25%
|
|
2021 Q2
|
0.27%
|
430,527
|
$34.69
|
$14,934,982
|
-14.84% (-75,000)
|
-0.05%
|
|
2019 Q4
|
0.32%
|
$29.45
|
+124.15% (+280,000)
|
|||
|
2019 Q3
|
0.14%
|
$26.59
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.